According to NICE guidance (NG28) , GLP-1 receptor agonists like Rybelsus may be considered when metformin is contraindicated or not tolerated, or as part of combination therapy when other treatments have not achieved adequate glycaemic control
Piana hoped to make a meaningful difference in the world by giving these high achievers the nutritional support they need to feel and function at their best, thus helping them achieve their goals and become the best possible version of themselves
Among these patients, 45.2% achieved a dose of 1 mg (injectable), and 14.2% reached 14 mg (oral) [1]
is a New York Stem Cell Foundation - Robertson Investigator (NYSCF-R-156) and is supported by the Wellcome Trust and Royal Society (211221/Z/18/Z) and a Ben Barres Early Career Acceleration Award from the Chan Zuckerberg Initiatives Neurodegeneration Challenge Network (CZI NDCN 191942)
Eligible adults include those with an initial BMI of 30 kg/m 2 and above, or 27 to 29.9 kg/m 2 in the presence of at least one weight-associated comorbidity
What is the main difference in how these medications work
